As for arm-level CNA events, GP1 and GP2 showed the lowest similarity (Supplementary Fig. 6l), indicating arm-level CNAs profoundly impacted the proteome and clinical outcomes of tRCC. The gene discussed is GP2; the disease is renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions.